Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty

Medacta

Status: Completed

Conditions: Hip Osteoarthritis

Treatments: Device: MPact Cup

Study type: Observational

Funder types: Industry

Identifiers

NCT03897595

P01.014.08/01

Details and patient eligibility

About

Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.

Enrollment: 187 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.

  • Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
  • Patients must be willing to comply with the pre and post-operative evaluation schedule

Exclusion criteria

• Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.

Trial design

187 participants in 1 patient group

Mpact cup

Description:

Quadra®-H, Quadra®-C, AMIStem®-H or AMIStem®-C femoral stem and Mpact® Acetabular hip system with CoCr Femoral Head or Ceramic MectaCer BIOLOX® Femoral Head

Treatment:

Device: MPact Cup